Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	To evaluate the efficacy of Molnupiravir compared to standard of care in confirmed RT-PCR positive patients with mild COVID-19.Timepoint: Rate of hospitalization from randomization up to Day 14.	To evaluate the efficacy of Molnupiravir compared to standard of care in confirmed RT-PCR positive patients with mild COVID-19.Timepoint: Rate of hospitalization from randomization up to Day 14.
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
May 27, 2021, 12:45 a.m.	oms	To evaluate the efficacy of Molnupiravir compared to standard of care in confirmed RT-PCR positive patients with mild COVID-19.Timepoint: Rate of hospitalization from randomization up to Day 14.	To evaluate the efficacy of Molnupiravir compared to standard of care in confirmed RT-PCR positive patients with mild COVID-19.Timepoint: Rate of hospitalization from randomization up to Day 14.